First biologic treatment for moderate-to-severe atopic dermatitis now available in Canada
Other articles you may be interested inView all
Dupixent (dupilumab) now reimbursed in Quebec
The Eczema Society of Canada is happy to share the exciting news that Dupixent™ (dupilumab), the first biologic therapy for the treatment of moderate-to-severe atopic dermatitis, is now reimbursed in Quebec. Quebec is the first...
Eczema Society of Canada releases “A Day with Eczema” video in recognition of Eczema Awareness Month
Eczema Society of Canada releases “A Day with Eczema” video in recognition of Eczema Awareness Month Video takes an intimate look into the life of a chronic eczema sufferer TORONTO, Nov. 5, 2019 / November is Eczema Awareness...
What is it really like to live #ADaywithEczema?
November is Eczema Awareness Month and ESC wants to know: What is it like to live #ADaywithEczema? It's more than just dry skin. November is Eczema Awareness Month, and ESC invites Canadians to watch and share "A Day with Eczema"-...